World’s First Portable & Low-Cost MRI Machine to Examine Hydrocephalus Patients

Hyperfine Research Inc. and Penn Medicine have teamed up to test out the world’s first portable MRI system. The clinical research study aims to look at whether the Hyperfine portable MRI machine can compete with the high-field MRI machines that are currently in use through several rounds of clinical studies.

In essence, the main goal of Hyperfine’s portable MRI system is to allow for any patients to receive an MRI without leaving their hospital bed while allowing doctors access to real-time images and monitoring. Additionally, the lower-cost allows for more patients and clinical settings to have access to an MRI machine. The device is pending in the FDA as a 510(k).

What Is Hydrocephalus?

Hydrocephalus is a possibly fatal condition in which there’s a buildup of cerebrospinal fluid within the brain. A person with hydrocephalus will experience various symptoms such as dizziness, headaches, gait complications, and varying cognitive impairments. Hydrocephalus could even lead to death in the most severe cases, but the new Hyperfine MRI device could bring significant advancements in monitoring and treating patients with this condition.

Study: ADHD Maybe Overlooked In Young Girls

PHOTO CREDIT: Flickr – CC BY 2.0 – ADHD by Practical Cures

A new NHS study suggests ADHD may be overlooked in young girls, as they tend to behave better than young boys.

The National Institute Of Health And Care Excellence (NICE) has reported findings that ADHD may be going untreated in young girls and women, who may be less likely to exhibit the most well-known traits of the condition. NICE reports that young girls with ADHD are more likely to exhibit behaviors that are harder to notice, such as having a hard time concentrating, poor organizational skills, and forgetfulness; none of which are traditionally linked to ‘hyperactivity’. According to the chairwoman of NICE’s guideline committee, Dr. Gillian Baird, nearly half of ADHD cases in young girls may go unnoticed. “Among the possibilities are that boys present with more obviously disruptive behavior,” Baird says.

Psychologists estimate that around 5% of school-age children suffer from ADHD, which is often characterized by restlessness and impulsiveness, which often lead to disruptive behavior in the classroom.

In recent years, treating ADHD with diet and nutrition has been gaining in popularity. NICE advises against treating ADHD in young children solely with nutrition, however. While elimination diets, like the popular Feingold Diet, have shown to be effective in treating ADHD for certain young children, it’s difficult to determine who will respond positively to elimination diets. NICE recommends only attempting to treat ADHD with special diets when consulting with a trained nutritionist and mental health experts.

Instead, NICE researchers advocate for regular doses of Ritalin, rather than relying on it as a last resort. Although Ritalin prescriptions have nearly doubled in the last decade, according to the NHS, the popular prescription drug is still not recommended as the first line of defense in treating ADHD.

ADHD experts recommend beginning with behavioral treatment or counseling first, with medication being prescribed only after attempts at modifying the environment have failed. NICE also recommends that only trained psychologists or mental health specialists prescribe Ritalin, going against the common wisdom that General Practitioners can prescribe behavioral medication.

The controversy in treatment and diagnosis hints at the crisis facing our children. ADHD – and related treatments – continues to rise. We need to continue to be vigilant so that every child can get the treatment that will work best for them.